{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:49:03Z","timestamp":1782935343141,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10529-026-03690-z","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:12:34Z","timestamp":1769497954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery of a multi-epitope tuberculosis vaccine targeting phospholipase C virulence factors: an insilico approach"],"prefix":"10.1007","volume":"48","author":[{"given":"Bhavin","family":"Maru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0817-5940","authenticated-orcid":false,"given":"Ashish","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"1","key":"3690_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01283-6","volume":"11","author":"A Albutti","year":"2021","unstructured":"Albutti A (2021) An integrated computational framework to design a multi-epitopes vaccine against Mycobacterium tuberculosis. Sci Rep 11(1):21929. https:\/\/doi.org\/10.1038\/s41598-021-01283-6","journal-title":"Sci Rep"},{"key":"3690_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molimm.2022.05.007","volume":"148","author":"MLF Alves","year":"2022","unstructured":"Alves MLF, Ferreira MRA, Rodrigues RR, Concei\u00e7\u00e3o FR (2022) Clostridium haemolyticum, a review of beta toxin and insights into the antigen design for vaccine development. Mol Immunol 148:45\u201353. https:\/\/doi.org\/10.1016\/j.molimm.2022.05.007","journal-title":"Mol Immunol"},{"key":"3690_CR3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.csbj.2023.01.019","volume":"21","author":"BT Andongma","year":"2023","unstructured":"Andongma BT, Huang Y, Chen F, Tang Q, Yang M, Chou S-H, Li X, He J (2023) In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosis. Comput Struct Biotechnol J 21:991\u20131004. https:\/\/doi.org\/10.1016\/j.csbj.2023.01.019","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"3690_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.7774\/cevr.2024.13.3.184","volume":"13","author":"MM Ari","year":"2024","unstructured":"Ari MM, Beig M, Sholeh M, Khoshmirsafa M (2024) The BCG vaccine, advantages, and disadvantages of introducing new generation vaccines against Mycobacterium tuberculosis. Clin Exp Vaccine Res 13(3):184\u2013201","journal-title":"Clin Exp Vaccine Res"},{"issue":"3","key":"3690_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1128\/CVI.00721-14","volume":"22","author":"K Bhatt","year":"2015","unstructured":"Bhatt K, Verma S, Ellner JJ, Salgame P (2015) Quest for correlates of protection against tuberculosis. Clin Vaccine Immunol 22(3):258\u2013266. https:\/\/doi.org\/10.1128\/CVI.00721-14","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"3690_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80899-6","volume":"11","author":"S Bibi","year":"2021","unstructured":"Bibi S, Ullah I, Zhu B, Adnan M, Liaqat R, Kong W-B, Niu S (2021) In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology. Sci Rep 11(1):1249. https:\/\/doi.org\/10.1038\/s41598-020-80899-6","journal-title":"Sci Rep"},{"issue":"27","key":"3690_CR7","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1016\/j.vaccine.2017.04.007","volume":"35","author":"C Boggiano","year":"2017","unstructured":"Boggiano C, Eichelberg K, Ramachandra L, Shea J, Ramakrishnan L, Behar S, Ernst JD, Porcelli SA, Maeurer M, Kornfeld H (2017) The impact of Mycobacterium tuberculosis immune evasion on protective immunity: implications for TB vaccine design\u201d \u2013 meeting report. Vaccine 35(27):3433\u20133440. https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.007","journal-title":"Vaccine"},{"key":"3690_CR8","doi-asserted-by":"publisher","unstructured":"Boubour A, Paradkar M, Thakur KT (2020) Chapter 1 - Global and regional burden of tuberculosis and tuberculous meningitis. In: Chin JH-C (Ed) Tuberculous Meningitis. Academic Press, https:\/\/doi.org\/10.1016\/B978-0-12-818825-5.00001-2","DOI":"10.1016\/B978-0-12-818825-5.00001-2"},{"issue":"10","key":"3690_CR9","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1194\/jlr.R057984","volume":"56","author":"L Cocco","year":"2015","unstructured":"Cocco L, Follo MY, Manzoli L, Suh P-G (2015) Phosphoinositide-specific phospholipase C in health and disease. J Lipid Res 56(10):1853\u20131860. https:\/\/doi.org\/10.1194\/jlr.R057984","journal-title":"J Lipid Res"},{"issue":"4","key":"3690_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/14760584.2019.1585246","volume":"18","author":"C Counoupas","year":"2019","unstructured":"Counoupas C, A. TJ, Britton WJ (2019) Deciphering protective immunity against tuberculosis: implications for vaccine development. Expert Rev Vaccines 18(4):353\u2013364. https:\/\/doi.org\/10.1080\/14760584.2019.1585246","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"3690_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01216-8","volume":"10","author":"Y Ding","year":"2025","unstructured":"Ding Y, Li Y, Wu Z, Zhou Y, Guo Y, Tian S, Yu R, Deng C, Wei R, Chen H, Li Y, Zhang X, Yu W, Jing C, Liu S, Qin L, Lyu M, Zou Y, Yao Y, Tan L, Wu S, Liu W, Chen X, Jin J (2025) A novel nanoparticle vaccine displaying multistage tuberculosis antigens confers protection in mice infected with H37Rv. NPJ Vaccines 10(1):173. https:\/\/doi.org\/10.1038\/s41541-025-01216-8","journal-title":"NPJ Vaccines"},{"issue":"8","key":"3690_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ni.1758","volume":"10","author":"M Divangahi","year":"2009","unstructured":"Divangahi M, Chen M, Gan H, Desjardins D, Hickman TT, Lee DM, Fortune S, Behar SM, Remold HG (2009) Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol 10(8):899\u2013906. https:\/\/doi.org\/10.1038\/ni.1758","journal-title":"Nat Immunol"},{"key":"3690_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117594","volume":"252","author":"S Fatima","year":"2020","unstructured":"Fatima S, Kumari A, Das G, Dwivedi VP (2020) Tuberculosis vaccine: a journey from BCG to present. Life Sci 252:117594. https:\/\/doi.org\/10.1016\/j.lfs.2020.117594","journal-title":"Life Sci"},{"issue":"4","key":"3690_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/trstmh\/trw016","volume":"110","author":"HA Fletcher","year":"2016","unstructured":"Fletcher HA, Schrager L (2016) TB vaccine development and the end TB strategy: importance and current status. Trans R Soc Trop Med Hyg 110(4):212\u2013218. https:\/\/doi.org\/10.1093\/trstmh\/trw016","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"3690_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1128\/mmbr.00082-15","volume":"80","author":"M Flores-D\u00edaz","year":"2016","unstructured":"Flores-D\u00edaz M, Monturiol-Gross L, Naylor C, Alape-Gir\u00f3n A, Flieger A (2016) Bacterial sphingomyelinases and phospholipases as virulence factors. Microbiol Mol Biol Rev 80(3):597\u2013628. https:\/\/doi.org\/10.1128\/mmbr.00082-15","journal-title":"Microbiol Mol Biol Rev"},{"issue":"11","key":"3690_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111844","volume":"10","author":"J Garc\u00eda-Machorro","year":"2022","unstructured":"Garc\u00eda-Machorro J, Ram\u00edrez-Salinas GL, Martinez-Archundia M, Correa-Basurto J (2022) The advantage of using immunoinformatic tools on vaccine design and development for coronavirus. Vaccines (Basel) 10(11):1844. https:\/\/doi.org\/10.3390\/vaccines10111844","journal-title":"Vaccines (Basel)"},{"issue":"03","key":"3690_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0038-1651492","volume":"39","author":"P Glaziou","year":"2018","unstructured":"Glaziou P, Floyd K, Raviglione MC (2018) Global epidemiology of tuberculosis. Semin Respir Crit Care Med 39(03):271\u2013285. https:\/\/doi.org\/10.1055\/s-0038-1651492","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"3690_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2174\/1389203717666160729093515","volume":"18","author":"J Glynis","year":"2017","unstructured":"Glynis J (2017) The \u03b1\/\u03b2 hydrolase fold proteins of Mycobacterium tuberculosis, with reference to their contribution to virulence. Curr Protein Pept Sci 18(3):190\u2013210. https:\/\/doi.org\/10.2174\/1389203717666160729093515","journal-title":"Curr Protein Pept Sci"},{"key":"3690_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.750496","volume":"12","author":"K Horv\u00e1ti","year":"2021","unstructured":"Horv\u00e1ti K, Fodor K, P\u00e1lyi B, Henczk\u00f3 J, Balka G, Gyulai G, Kiss \u00c9, Biri-Kov\u00e1cs B, Senoner Z, B\u0151sze S (2021) Novel assay platform to evaluate intracellular killing of Mycobacterium tuberculosis: in vitro and in vivo validation. Front Immunol 12:750496. https:\/\/doi.org\/10.3389\/fimmu.2021.750496","journal-title":"Front Immunol"},{"issue":"9","key":"3690_CR20","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1002\/jmv.27017","volume":"93","author":"S Ishack","year":"2021","unstructured":"Ishack S, Lipner SR (2021) Bioinformatics and immunoinformatics to support COVID-19 vaccine development. J Med Virol 93(9):5209\u20135211. https:\/\/doi.org\/10.1002\/jmv.27017","journal-title":"J Med Virol"},{"key":"3690_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1280299","volume":"14","author":"F Jiang","year":"2023","unstructured":"Jiang F, Han Y, Liu Y, Xue Y, Cheng P, Xiao L, Gong W (2023) A comprehensive approach to developing a multi-epitope vaccine against Mycobacterium tuberculosis: from in silico design to in vitro immunization evaluation. Front Immunol 14:1280299. https:\/\/doi.org\/10.3389\/fimmu.2023.1280299","journal-title":"Front Immunol"},{"issue":"1","key":"3690_CR22","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1080\/21505594.2021.1990660","volume":"12","author":"H Joshi","year":"2021","unstructured":"Joshi H, Kandari D, Bhatnagar R (2021) Insights into the molecular determinants involved in Mycobacterium tuberculosis persistence and their therapeutic implications. Virulence 12(1):2721\u20132749. https:\/\/doi.org\/10.1080\/21505594.2021.1990660","journal-title":"Virulence"},{"issue":"2","key":"3690_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.18535\/cmhrj.v4i2.332","volume":"4","author":"MMA Khan","year":"2024","unstructured":"Khan MMA, Fahim S, Muheb MR, Ahmadi S (2024) Short overview of the burden of tuberculosis. Clin Med Health Res J 4(2):829\u2013832. https:\/\/doi.org\/10.18535\/cmhrj.v4i2.332","journal-title":"Clin Med Health Res J"},{"key":"3690_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1193058\/full","author":"H Kim","year":"2023","unstructured":"Kim H, Choi H-G, Shin SJ (2023) Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1193058\/full","journal-title":"Front Immunol"},{"issue":"12","key":"3690_CR25","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.1128\/jcm.43.12.6048-6053.2005","volume":"43","author":"Y Kong","year":"2005","unstructured":"Kong Y, Cave MD, Yang D, Zhang L, Marrs CF, Foxman B, Bates JH, Wilson F, Mukasa LN, Yang ZH (2005) Distribution of insertion- and deletion-associated genetic polymorphisms among four Mycobacterium tuberculosis phospholipase C genes and associations with extrathoracic tuberculosis: a population-based study. J Clin Microbiol 43(12):6048\u20136053. https:\/\/doi.org\/10.1128\/jcm.43.12.6048-6053.2005","journal-title":"J Clin Microbiol"},{"issue":"1","key":"3690_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep16918","volume":"5","author":"F Le Chevalier","year":"2015","unstructured":"Le Chevalier F, Cascioferro A, Frigui W, Pawlik A, Boritsch EC, Bottai D, Majlessi L, Herrmann JL, Brosch R (2015) Revisiting the role of phospholipases C in virulence and the lifecycle of Mycobacterium tuberculosis. Sci Rep 5(1):16918. https:\/\/doi.org\/10.1038\/srep16918","journal-title":"Sci Rep"},{"issue":"18","key":"3690_CR27","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.vaccine.2015.03.030","volume":"33","author":"V Le Moigne","year":"2015","unstructured":"Le Moigne V, Rottman M, Goulard C, Barteau B, Poncin I, Soismier N, Canaan S, Pitard B, Gaillard J-L, Herrmann J-L (2015) Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: the Mycobacterium abscessus model. Vaccine 33(18):2118\u20132124. https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.030","journal-title":"Vaccine"},{"key":"3690_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01452\/full","author":"E Nemes","year":"2020","unstructured":"Nemes E, Khader SA, Swanson RV, Hanekom WA (2020) Targeting unconventional host components for vaccination-induced protection against TB. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.01452\/full","journal-title":"Front Immunol"},{"issue":"3","key":"3690_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.synbio.2024.03.010","volume":"9","author":"TL Nguyen","year":"2024","unstructured":"Nguyen TL, Kim H (2024) Discovering peptides and computational investigations of a multiepitope vaccine target Mycobacterium tuberculosis. Synth Syst Biotechnol 9(3):391\u2013405. https:\/\/doi.org\/10.1016\/j.synbio.2024.03.010","journal-title":"Synth Syst Biotechnol"},{"issue":"4","key":"3690_CR30","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1002\/jcb.27783","volume":"120","author":"R Paroha","year":"2019","unstructured":"Paroha R, Chaurasiya SK, Chourasia R (2019) Phospholipase C-\u03b32 promotes intracellular survival of mycobacteria. J Cell Biochem 120(4):5062\u20135071. https:\/\/doi.org\/10.1002\/jcb.27783","journal-title":"J Cell Biochem"},{"issue":"2","key":"3690_CR31","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.4081\/idr.2016.6570","volume":"8","author":"M Raviglione","year":"2016","unstructured":"Raviglione M, Sulis G (2016) Tuberculosis 2015: burden, challenges and strategy for control and elimination. Infect Dis Rep 8(2):6570. https:\/\/doi.org\/10.4081\/idr.2016.6570","journal-title":"Infect Dis Rep"},{"issue":"1","key":"3690_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1365-2958.2002.03009.x","volume":"45","author":"C Raynaud","year":"2002","unstructured":"Raynaud C, Guilhot C, Rauzier J, Bordat Y, Pelicic V, Manganelli R, Smith I, Gicquel B, Jackson M (2002) Phospholipases C are involved in the virulence of Mycobacterium tuberculosis. Mol Microbiol 45(1):203\u2013217. https:\/\/doi.org\/10.1046\/j.1365-2958.2002.03009.x","journal-title":"Mol Microbiol"},{"key":"3690_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020654","author":"L Saldanha","year":"2023","unstructured":"Saldanha L, Langel \u00dc, Vale N (2023) In silico studies to support vaccine development. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15020654","journal-title":"Pharmaceutics"},{"issue":"1","key":"3690_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14760584.2019.1552140","volume":"18","author":"I Satti","year":"2019","unstructured":"Satti I, McShane H (2019) Current approaches toward identifying a correlate of immune protection from tuberculosis. Expert Rev Vaccines 18(1):43\u201359. https:\/\/doi.org\/10.1080\/14760584.2019.1552140","journal-title":"Expert Rev Vaccines"},{"key":"3690_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1677868","volume":"16","author":"A Shaji","year":"2025","unstructured":"Shaji A, Verma A, Bhaskar A, Dwivedi VP (2025) Correction: BCG and beyond: unlocking new frontiers in TB vaccine development. Front Immunol 16:1677868. https:\/\/doi.org\/10.3389\/fimmu.2025.1677868","journal-title":"Front Immunol"},{"issue":"1","key":"3690_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93266-w","volume":"11","author":"R Sharma","year":"2021","unstructured":"Sharma R, Rajput VS, Jamal S, Grover A, Grover S (2021) An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins. Sci Rep 11(1):13836. https:\/\/doi.org\/10.1038\/s41598-021-93266-w","journal-title":"Sci Rep"},{"issue":"1","key":"3690_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29252\/vacres.3.8.9.36","volume":"4","author":"SH Tafreshi","year":"2017","unstructured":"Tafreshi SH (2017) BCG vaccine and pulmonary tuberculosis. Vacres 4(1):1\u20135. https:\/\/doi.org\/10.29252\/vacres.3.8.9.36","journal-title":"Vacres"},{"key":"3690_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126932","volume":"53","author":"S Tengattini","year":"2025","unstructured":"Tengattini S, Bavaro T, Rinaldi F, Temporini C, Pollegioni L, Terreni M, Piubelli L (2025) Novel tuberculosis vaccines based on TB10.4 and Ag85B: state-of-art and advocacy for good practices. Vaccine 53:126932. https:\/\/doi.org\/10.1016\/j.vaccine.2025.126932","journal-title":"Vaccine"},{"issue":"4","key":"3690_CR39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1099\/mic.0.26778-0","volume":"150","author":"C Viana-Niero","year":"2004","unstructured":"Viana-Niero C, de Haas PE, van Soolingen D, Le\u00e3o SC (2004) Analysis of genetic polymorphisms affecting the four phospholipase C (plc) genes in Mycobacterium tuberculosis complex clinical isolates. Microbiol (Read Engl) 150(4):967\u2013978. https:\/\/doi.org\/10.1099\/mic.0.26778-0","journal-title":"Microbiol (Read Engl)"},{"issue":"1","key":"3690_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-01004-w","volume":"9","author":"J Wang","year":"2024","unstructured":"Wang J, Fan X-Y, Hu Z (2024) Immune correlates of protection as a game changer in tuberculosis vaccine development. NPJ Vaccines 9(1):208. https:\/\/doi.org\/10.1038\/s41541-024-01004-w","journal-title":"NPJ Vaccines"},{"key":"3690_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/25151355221100218","volume":"10","author":"V Yurina","year":"2022","unstructured":"Yurina V, Adianingsih OR (2022) Predicting epitopes for vaccine development using bioinformatics tools. Ther Adv Vaccines Immunother 10:25151355221100218. https:\/\/doi.org\/10.1177\/25151355221100218","journal-title":"Ther Adv Vaccines Immunother"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-026-03690-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-026-03690-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-026-03690-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T04:37:53Z","timestamp":1771043873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10529-026-03690-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3690"],"URL":"https:\/\/doi.org\/10.1007\/s10529-026-03690-z","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"25"}}